Maccura Biotechnology Co.Ltd (300463.SZ)
CNY 13.88
(0.51%)
CNY 13.88
(0.51%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 901.51 Million | 843.21 Million | 1.61 Billion | 1.09 Billion | 459.51 Million | 193.9 Million |
| Net Income | 304.67 Million | 701.39 Million | 1 Billion | 821.35 Million | 565.68 Million | 482.91 Million |
| Depreciation & Amortization | 313.08 Million | 270.19 Million | 236.19 Million | 205.21 Million | 155.49 Million | 121.78 Million |
| Deferred income taxes | -34.3 Million | -29.62 Million | 63.98 Million | -20 Million | 26.81 Million | 29.39 Million |
| Stock-based compensation | - | - | 1.04 Million | 6.19 Million | 31.67 Million | 24.54 Million |
| Change in working capital | 139.98 Million | -244.01 Million | 256.45 Million | -53.54 Million | -379 Million | -494.56 Million |
| Other non-cash items | 37.16 Million | 115.63 Million | 56.74 Million | 134.83 Million | 58.84 Million | 83.76 Million |
| Investing Cash Flow | -503.04 Million | -1.82 Billion | -686.81 Million | -502.52 Million | -514.44 Million | -419 Million |
| Investments in PPE | -877.9 Million | -987.74 Million | -601.78 Million | -501.31 Million | -504.67 Million | -529.94 Million |
| Acquisitions | 9.48 Million | -164.57 Million | -66.98 Million | -57.06 Million | -60.19 Million | -45.27 Million |
| Investment purchases | -1.77 Billion | -2.41 Billion | -87.5 Million | -5 Million | -11 Million | - |
| Sales/Maturities of investments | 2.13 Billion | 1.72 Billion | 520 Thousand | 57.06 Million | 60.19 Million | 106.8 Million |
| Other Investing Activities | -8.68 Million | 20.24 Million | 68.93 Million | 3.79 Million | 1.22 Million | 4.13 Million |
| Financing Cash Flow | -152.75 Million | 930.04 Million | -894.69 Million | -433.37 Million | 94.31 Million | 277.34 Million |
| Debt repayment | -113.72 Million | -309.31 Million | -1.09 Billion | -1.23 Billion | -1.05 Billion | -686.13 Million |
| Dividends payments | -212.52 Million | -286.63 Million | -238.44 Million | -105.4 Million | -89.28 Million | -122.75 Million |
| Common Stock Repurchased | - | - | -175.42 Million | -6.49 Million | - | - |
| Common Stock Issuance | - | -406 Thousand | 175.42 Million | 6.49 Million | - | - |
| Other Financing Activities | -19.31 Million | 1.55 Billion | 501.5 Million | 979.86 Million | 1.3 Billion | 1.08 Billion |
| Accounts receivables | 214.65 Million | -277.51 Million | 257.65 Million | -162.58 Million | -432.91 Million | -573.33 Million |
| Accounts payables | -51.45 Million | 47.91 Million | -45.96 Million | 369.94 Million | 154.79 Million | 237.01 Million |
| Inventory | 11.09 Million | 15.2 Million | -19.22 Million | -240.89 Million | -127.7 Million | -187.63 Million |
| Other working capital | -85.76 Million | -29.62 Million | 63.98 Million | -20 Million | 26.81 Million | -306.92 Million |
| Cash at beginning of period | 564.29 Million | 615.67 Million | 582.64 Million | 429.89 Million | 390.32 Million | 337.88 Million |
| Cash at end of period | 811.36 Million | 564.29 Million | 615.67 Million | 582.64 Million | 429.89 Million | 390.32 Million |
| Capital Expenditure | -877.9 Million | -987.74 Million | -601.78 Million | -501.31 Million | -504.67 Million | -529.94 Million |
| Effect of forex changes on cash | 1.35 Million | 5.19 Million | -2.15 Million | -5.39 Million | 173.59 Thousand | 197.25 Thousand |
| Net cash flow / Change in cash | 247.06 Million | -51.37 Million | 33.02 Million | 152.75 Million | 39.56 Million | 52.44 Million |
| Free Cash Flow | 23.6 Million | -144.52 Million | 1.01 Billion | 592.72 Million | -45.15 Million | -336.04 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 79.64 Million | 81.28 Million | 120.44 Million | 43.94 Million | 304.67 Million | 93.84 Million |
| Depreciation & Amortization | - | 72.71 Million | 72.71 Million | 87.59 Million | 313.08 Million | -141.34 Million |
| Deferred income taxes | - | - | - | - | -34.3 Million | - |
| Stock-based compensation | - | 1.98 Million | - | - | - | - |
| Change in working capital | - | 20.51 Million | - | 225.74 Million | 139.98 Million | -194.79 Million |
| Other non-cash items | 201.46 Million | 200.07 Million | -113.59 Million | 325.98 Million | 37.16 Million | 449.69 Million |
| Investing Cash Flow | -249.03 Million | -252.59 Million | -41.42 Million | -199.36 Million | -503.04 Million | -162.57 Million |
| Investments in PPE | -274.29 Million | -253.13 Million | -211.42 Million | -312.66 Million | -877.9 Million | -219.41 Million |
| Acquisitions | 4.47 Million | 547.14 Thousand | 5860.00 | 11.42 Million | 9.48 Million | -5.94 Million |
| Investment purchases | -120 Million | -140 Million | -140 Million | -310.25 Million | -1.77 Billion | -410 Million |
| Sales/Maturities of investments | 140.79 Million | 140 Million | 310 Million | 412.13 Million | 2.13 Billion | 473.27 Million |
| Other Investing Activities | 4.47 Million | 1.39 Million | 171.96 Million | 113.3 Million | -8.68 Million | -500 Thousand |
| Financing Cash Flow | -152.04 Million | 179.84 Million | 16.16 Million | -19.66 Million | -152.75 Million | -130.79 Million |
| Debt repayment | -36.34 Million | -161.56 Million | -47.5 Million | -3.47 Million | -113.72 Million | -131.12 Million |
| Dividends payments | -99.45 Million | -5.24 Million | -5.35 Million | -212.52 Million | -212.52 Million | -6.86 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -2.61 Million | 2.61 Million | - | - | - | - |
| Other Financing Activities | -16.24 Million | 15.66 Million | -31.33 Million | -11.06 Million | -19.31 Million | 7.19 Million |
| Accounts receivables | - | 94.97 Million | - | 214.65 Million | 214.65 Million | -281.81 Million |
| Accounts payables | - | - | - | - | -51.45 Million | - |
| Inventory | - | -74.46 Million | - | 11.09 Million | 11.09 Million | 87.01 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 929.06 Million | 819.18 Million | 769.65 Million | 746.99 Million | 564.29 Million | 832.03 Million |
| Cash at end of period | 806.05 Million | 952.96 Million | 819.18 Million | 811.36 Million | 811.36 Million | 746.99 Million |
| Capital Expenditure | -274.29 Million | -253.13 Million | -211.42 Million | -312.66 Million | -877.9 Million | -219.41 Million |
| Effect of forex changes on cash | -2.24 Million | 49.53 Thousand | 167.45 Thousand | -994.98 Thousand | 1.35 Million | 933.9 Thousand |
| Net cash flow / Change in cash | -123 Million | 133.78 Million | 49.52 Million | 64.36 Million | 247.06 Million | -85.04 Million |
| Free Cash Flow | 6.81 Million | -44.49 Million | -204.58 Million | -30.34 Million | 23.6 Million | -12.01 Million |
SPRINT
UGPA3
BLLB
2643
ALL
DLICY